Product Comparison


Glaxo Smith Kline 58160082311
Glaxo Smith Kline 58160081912
McKesson # 1081079 1080947
Description Shingrix® Shingles Vaccine Indicated for People 50 Years of Age and Older Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL Shingrix® Shingles Vaccine Indicated for People 50 Years of Age and Older Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL
Manufacturer # 58160082311 58160081912
Brand Shingrix® Shingrix®
Manufacturer Glaxo Smith Kline Glaxo Smith Kline
发票 SHINGRIX VACC, SDV 50MCG/0.5ML0.5ML (10/BX) SHINGRIX VACC, SDV 50MCG/0.5ML0.5ML
Log In to Order Log In to Order

Comparison

Alternate Manufacturer Number 3739620
NDC Number 58160082311 58160-0819-12
Application Shingles Vaccine Shingles Vaccine
Container Type Single-Dose Vial Single-Dose Vial
Country of Origin Unknown Unknown
Dosage Form Injection Injection
Generic Drug Code 43989 43989
Generic Drug Name Zoster Vaccine Recombinant, Adjuvanted Zoster Vaccine Recombinant, Adjuvanted
Product Dating McKesson Acceptable Dating: we will ship >= 180 days McKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires Refrigeration Requires Refrigeration
Strength 50 mcg / 0.5 mL 50 mcg / 0.5 mL
Type Intramuscular Intramuscular
UNSPSC Code 51201650 51201650
User Indicated for People 50 Years of Age and Older Indicated for People 50 Years of Age and Older
Volume 0.5 mL 0.5 mL
Features and Benefits
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
  • SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy
  • SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
  • 一剂after reconstitution is 0.5 mL
  • Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months
  • 10 Doses
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
  • SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
  • SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
  • 一剂after reconstitution is 0.5 mL
  • Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months
  • 1 Dose